Umeå University's logo

umu.sePublications
Change search
Link to record
Permanent link

Direct link
Rentoft, Matilda
Alternative names
Publications (10 of 20) Show all publications
Breeur, M., Ferrari, P., Dossus, L., Jenab, M., Johansson, M., Rinaldi, S., . . . Viallon, V. (2022). Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. BMC Medicine, 20(1), Article ID 351.
Open this publication in new window or tab >>Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition
Show others...
2022 (English)In: BMC Medicine, E-ISSN 1741-7015, Vol. 20, no 1, article id 351Article in journal (Refereed) Published
Abstract [en]

Background: Epidemiological studies of associations between metabolites and cancer risk have typically focused on specific cancer types separately. Here, we designed a multivariate pan-cancer analysis to identify metabolites potentially associated with multiple cancer types, while also allowing the investigation of cancer type-specific associations.

Methods: We analysed targeted metabolomics data available for 5828 matched case-control pairs from cancer-specific case-control studies on breast, colorectal, endometrial, gallbladder, kidney, localized and advanced prostate cancer, and hepatocellular carcinoma nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. From pre-diagnostic blood levels of an initial set of 117 metabolites, 33 cluster representatives of strongly correlated metabolites and 17 single metabolites were derived by hierarchical clustering. The mutually adjusted associations of the resulting 50 metabolites with cancer risk were examined in penalized conditional logistic regression models adjusted for body mass index, using the data-shared lasso penalty.

Results: Out of the 50 studied metabolites, (i) six were inversely associated with the risk of most cancer types: glutamine, butyrylcarnitine, lysophosphatidylcholine a C18:2, and three clusters of phosphatidylcholines (PCs); (ii) three were positively associated with most cancer types: proline, decanoylcarnitine, and one cluster of PCs; and (iii) 10 were specifically associated with particular cancer types, including histidine that was inversely associated with colorectal cancer risk and one cluster of sphingomyelins that was inversely associated with risk of hepatocellular carcinoma and positively with endometrial cancer risk.

Conclusions: These results could provide novel insights for the identification of pathways for cancer development, in particular those shared across different cancer types.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2022
Keywords
Breast, Cancer, Colorectal, Endometrial, EPIC, Kidney, Lasso, Liver, Metabolomics, Prostate
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:umu:diva-200663 (URN)10.1186/s12916-022-02553-4 (DOI)000869850300002 ()36258205 (PubMedID)2-s2.0-85140184323 (Scopus ID)
Funder
EU, FP7, Seventh Framework Programme, 2014/1193EU, FP7, Seventh Framework Programme, 313010EU, FP7, Seventh Framework Programme, C19335/A21351Swedish Cancer SocietySwedish Research Council
Available from: 2022-11-07 Created: 2022-11-07 Last updated: 2023-09-05Bibliographically approved
Rentoft, M., Melin, B. S., Wibom, C. & Björkblom, B. (2022). Robusta biomarkörer för prediktion av risk och sjukdom: en utvärdering av reproducerbarheten hos de stora kommersiella omik-plattformarna. Umeå universitet
Open this publication in new window or tab >>Robusta biomarkörer för prediktion av risk och sjukdom: en utvärdering av reproducerbarheten hos de stora kommersiella omik-plattformarna
2022 (Swedish)Report (Other (popular science, discussion, etc.))
Abstract [sv]

I och med utveckling inom storskalig analys av blodprover har man idag insett nyttan av att omvandla biobanker med lagrade humanprover till data-banker där forskare snabbt kan få tillgång till data för att svara på forsknings-frågor. Problemet är att många av teknikerna för att skapa storskaliga data är semikvantitativa, värdena går inte att relatera till en absolut koncentration och är därmed svåra att slå samman och jämföra över tid. Randomisering, det vill säga att proverna analyseras i slumpvis inbördes ordning, är en av de viktigas-te aspekterna för att skapa data som går att slå samman och återanvända för många forskningsfrågor. Detta underlättar korrigering av oönskade analysva-riationer över tid. Utöver detta kan man använda sig av bryggningsprover, QC-prov (kvalitetskontrollprov) eller ankarprover, som analyseras upprepat både inom och mellan analystillfällen, vilket underlättar att lägga samman dataset som analyseras vid olika tillfällen.

Många kommersiella analysplattformar inkluderar ett eget QC-prov i analysen och vissa delar med sig av data för dessa prover. Det vore värdefullt om alla plattformar delade dessa data för kvalitetsutvärdering och eventuell korrige-ring av analysvariationer över tid. För alla semikvantitativa plattformar som undersöktes (Olink, Somalogic, Metabolon och Biocrates) var den tekniska variabiliteten mellan QC-proverna betydligt lägre än variabiliteten mellan ana-lyserade plasmaprover. Detta var tydligast för proteomikplattformarna, vilket antyder att förutsättningarna att upptäcka biologiska skillnader är bättre i pro-teomikdata. Undantaget från detta är en femte plattform, Nightingale, en kvan-titativ men smalare metabololmikmetod som anses generera stabila mätningar.

Vid all utveckling av biomarkörpaneler för att prediktera sjukdom behöver man göra upptäcktsanalyser, sedan valideringsstudier och därefter tester i den situation man tänker att testet ska fungera. De breda omikplattformarna läm-par sig för upptäckt och eventuellt validering, men för det faktiska kliniska tes-tet behövs en kvantitativ analys för att verkligen utvärdera att de proteiner eller metaboliter man vill använda är stabilt uppmätbara och fungerar för att pre-diktera sjukdom eller risk för sjukdom.

Place, publisher, year, edition, pages
Umeå universitet, 2022. p. 17
National Category
Clinical Medicine
Identifiers
urn:nbn:se:umu:diva-201292 (URN)
Funder
Vinnova, 2020-03055
Available from: 2022-11-28 Created: 2022-11-28 Last updated: 2022-11-28Bibliographically approved
Viallon, V., His, M., Rinaldi, S., Breeur, M., Gicquiau, A., Hemon, B., . . . Ferrari, P. (2021). A new pipeline for the normalization and pooling of metabolomics data. Metabolites, 11(9), Article ID 631.
Open this publication in new window or tab >>A new pipeline for the normalization and pooling of metabolomics data
Show others...
2021 (English)In: Metabolites, ISSN 2218-1989, E-ISSN 2218-1989, Vol. 11, no 9, article id 631Article in journal (Refereed) Published
Abstract [en]

Pooling metabolomics data across studies is often desirable to increase the statistical power of the analysis. However, this can raise methodological challenges as several preanalytical and analytical factors could introduce differences in measured concentrations and variability between datasets. Specifically, different studies may use variable sample types (e.g., serum versus plasma) collected, treated, and stored according to different protocols, and assayed in different laboratories using different instruments. To address these issues, a new pipeline was developed to normalize and pool metabolomics data through a set of sequential steps: (i) exclusions of the least informative observations and metabolites and removal of outliers; imputation of missing data; (ii) identification of the main sources of variability through principal component partial R-square (PC-PR2) analysis; (iii) application of linear mixed models to remove unwanted variability, including samples’ originating study and batch, and preserve biological variations while accounting for potential differences in the residual variances across studies. This pipeline was applied to targeted metabolomics data acquired using Biocrates AbsoluteIDQ kits in eight case-control studies nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Comprehensive examination of metabolomics measurements indicated that the pipeline improved the comparability of data across the studies. Our pipeline can be adapted to normalize other molecular data, including biomarkers as well as proteomics data, and could be used for pooling molecular datasets, for example in international consortia, to limit biases introduced by inter-study variability. This versatility of the pipeline makes our work of potential interest to molecular epidemiologists.

Place, publisher, year, edition, pages
MDPI, 2021
Keywords
Cancer epidemiology, Metabolites, Metabolomics, Normalization, Pooling, Technical variability
National Category
Cancer and Oncology Bioinformatics (Computational Biology)
Research subject
Oncology
Identifiers
urn:nbn:se:umu:diva-188135 (URN)10.3390/metabo11090631 (DOI)000701760400001 ()34564446 (PubMedID)2-s2.0-85115861814 (Scopus ID)
Note

(This article belongs to the Special Issue Metabolomics Meets Epidemiology).

Available from: 2021-10-05 Created: 2021-10-05 Last updated: 2023-09-05Bibliographically approved
Svensson, D., Rentoft, M., Dahlin, A. M., Lundholm, E., Olason, P. I., Sjödin, A., . . . Johansson, E. (2020). A whole-genome sequenced control population in northern Sweden reveals subregional genetic differences. PLOS ONE, 15(9), Article ID e0237721.
Open this publication in new window or tab >>A whole-genome sequenced control population in northern Sweden reveals subregional genetic differences
Show others...
2020 (English)In: PLOS ONE, E-ISSN 1932-6203, Vol. 15, no 9, article id e0237721Article in journal (Refereed) Published
Abstract [en]

The number of national reference populations that are whole-genome sequenced are rapidly increasing. Partly driving this development is the fact that genetic disease studies benefit from knowing the genetic variation typical for the geographical area of interest. A whole-genome sequenced Swedish national reference population (n = 1000) has been recently published but with few samples from northern Sweden. In the present study we have whole-genome sequenced a control population (n = 300) (ACpop) from Västerbotten County, a sparsely populated region in northern Sweden previously shown to be genetically different from southern Sweden. The aggregated variant frequencies within ACpop are publicly available (DOI 10.17044/NBIS/G000005) to function as a basic resource in clinical genetics and for genetic studies. Our analysis of ACpop, representing approximately 0.11% of the population in Västerbotten, indicates the presence of a genetic substructure within the county. Furthermore, a demographic analysis showed that the population from which samples were drawn was to a large extent geographically stationary, a finding that was corroborated in the genetic analysis down to the level of municipalities. Including ACpop in the reference population when imputing unknown variants in a Västerbotten cohort resulted in a strong increase in the number of high-confidence imputed variants (up to 81% for variants with minor allele frequency < 5%). ACpop was initially designed for cancer disease studies, but the genetic structure within the cohort will be of general interest for all genetic disease studies in northern Sweden.

Place, publisher, year, edition, pages
Public Library Science, 2020
National Category
Medical Genetics
Identifiers
urn:nbn:se:umu:diva-175837 (URN)10.1371/journal.pone.0237721 (DOI)000571887500123 ()32915809 (PubMedID)2-s2.0-85090917774 (Scopus ID)
Available from: 2020-10-16 Created: 2020-10-16 Last updated: 2023-03-23Bibliographically approved
Crawford, T., Karamat, F., Lehotai, N., Rentoft, M., Blomberg, J., Strand, Å. & Björklund, S. (2020). Specific functions for Mediator complex subunits from different modules in the transcriptional response of Arabidopsis thaliana to abiotic stress. Scientific Reports, 10(1), Article ID 5073.
Open this publication in new window or tab >>Specific functions for Mediator complex subunits from different modules in the transcriptional response of Arabidopsis thaliana to abiotic stress
Show others...
2020 (English)In: Scientific Reports, E-ISSN 2045-2322, Vol. 10, no 1, article id 5073Article in journal (Refereed) Published
Abstract [en]

Adverse environmental conditions are detrimental to plant growth and development. Acclimation to abiotic stress conditions involves activation of signaling pathways which often results in changes in gene expression via networks of transcription factors (TFs). Mediator is a highly conserved co-regulator complex and an essential component of the transcriptional machinery in eukaryotes. Some Mediator subunits have been implicated in stress-responsive signaling pathways; however, much remains unknown regarding the role of plant Mediator in abiotic stress responses. Here, we use RNA-seq to analyze the transcriptional response of Arabidopsis thaliana to heat, cold and salt stress conditions. We identify a set of common abiotic stress regulons and describe the sequential and combinatorial nature of TFs involved in their transcriptional regulation. Furthermore, we identify stress-specific roles for the Mediator subunits MED9, MED16, MED18 and CDK8, and putative TFs connecting them to different stress signaling pathways. Our data also indicate different modes of action for subunits or modules of Mediator at the same gene loci, including a co-repressor function for MED16 prior to stress. These results illuminate a poorly understood but important player in the transcriptional response of plants to abiotic stress and identify target genes and mechanisms as a prelude to further biochemical characterization.

Place, publisher, year, edition, pages
Nature Publishing Group, 2020
National Category
Bioinformatics and Systems Biology
Identifiers
urn:nbn:se:umu:diva-175085 (URN)10.1038/s41598-020-61758-w (DOI)000563443900012 ()32193425 (PubMedID)2-s2.0-85082040402 (Scopus ID)
Funder
Knut and Alice Wallenberg Foundation, 2015-0056Swedish Research Council, 201603943Swedish Research Council, 2016-04319Swedish Foundation for Strategic Research , SB16-0089
Available from: 2020-10-01 Created: 2020-10-01 Last updated: 2023-03-23Bibliographically approved
Obi, I., Rentoft, M., Singh, V., Jamroskovic, J., Chand, K., Chorell, E., . . . Sabouri, N. (2020). Stabilization of G-quadruplex DNA structures in Schizosaccharomyces pombe causes single-strand DNA lesions and impedes DNA replication. Nucleic Acids Research, 48(19), 10998-11015
Open this publication in new window or tab >>Stabilization of G-quadruplex DNA structures in Schizosaccharomyces pombe causes single-strand DNA lesions and impedes DNA replication
Show others...
2020 (English)In: Nucleic Acids Research, ISSN 0305-1048, E-ISSN 1362-4962, Vol. 48, no 19, p. 10998-11015Article in journal (Refereed) Published
Abstract [en]

G-quadruplex (G4) structures are stable noncanonical DNA structures that are implicated in the regulation of many cellular pathways. We show here that the G4-stabilizing compound PhenDC3 causes growth defects in Schizosaccharomyces pombe cells, especially during S-phase in synchronized cultures. By visualizing individual DNA molecules, we observed shorter DNA fragments of newly replicated DNA in the PhenDC3-treated cells, suggesting that PhenDC3 impedes replication fork progression. Furthermore, a novel single DNA molecule damage assay revealed increased single-strand DNA lesions in the PhenDC3-treated cells. Moreover, chromatin immunoprecipitation showed enrichment of the leading-strand DNA polymerase at sites of predicted G4 structures, suggesting that these structures impede DNA replication. We tested a subset of these sites and showed that they form G4 structures, that they stall DNA synthesis in vitro and that they can be resolved by the breast cancerassociated Pif1 family helicases. Our results thus suggest that G4 structures occur in S. pombe and that stabilized/unresolved G4 structures are obstacles for the replication machinery. The increased levels of DNA damage might further highlight the association of the human Pif1 helicase with familial breast cancer and the onset of other human diseases connected to unresolved G4 structures.

Place, publisher, year, edition, pages
Oxford University Press, 2020
National Category
Medical and Health Sciences
Research subject
molecular medicine (genetics and pathology); Medical Biochemistry
Identifiers
urn:nbn:se:umu:diva-176331 (URN)10.1093/nar/gkaa820 (DOI)000606018400033 ()2-s2.0-85095799661 (Scopus ID)
Funder
Knut and Alice Wallenberg Foundation, KAW2015–0189Swedish Research Council, 2018–02651Swedish Research Council, 2017–05235Swedish Cancer Society, 2019/126Swedish Cancer Society, 2017/654The Kempe Foundations, SMK-1632Swedish Childhood Cancer Foundation, MT2016–0004Swedish Childhood Cancer Foundation, PR2019–0037Swedish Research Council, 2018–02651
Available from: 2020-10-29 Created: 2020-10-29 Last updated: 2023-03-24Bibliographically approved
Rentoft, M., Svensson, D., Sjödin, A., Olason, P. I., Sjöström, O., Nylander, C., . . . Johansson, E. (2019). A geographically matched control population efficiently limits the number of candidate disease-causing variants in an unbiased whole-genome analysis. PLOS ONE, 14(3), Article ID e0213350.
Open this publication in new window or tab >>A geographically matched control population efficiently limits the number of candidate disease-causing variants in an unbiased whole-genome analysis
Show others...
2019 (English)In: PLOS ONE, E-ISSN 1932-6203, Vol. 14, no 3, article id e0213350Article in journal (Refereed) Published
Abstract [en]

Whole-genome sequencing is a promising approach for human autosomal dominant disease studies. However, the vast number of genetic variants observed by this method constitutes a challenge when trying to identify the causal variants. This is often handled by restricting disease studies to the most damaging variants, e.g. those found in coding regions, and overlooking the remaining genetic variation. Such a biased approach explains in part why the genetic causes of many families with dominantly inherited diseases, in spite of being included in whole-genome sequencing studies, are left unsolved today. Here we explore the use of a geographically matched control population to minimize the number of candidate disease-causing variants without excluding variants based on assumptions on genomic position or functional predictions. To exemplify the benefit of the geographically matched control population we apply a typical disease variant filtering strategy in a family with an autosomal dominant form of colorectal cancer. With the use of the geographically matched control population we end up with 26 candidate variants genome wide. This is in contrast to the tens of thousands of candidates left when only making use of available public variant datasets. The effect of the local control population is dual, it (1) reduces the total number of candidate variants shared between affected individuals, and more importantly (2) increases the rate by which the number of candidate variants are reduced as additional affected family members are included in the filtering strategy. We demonstrate that the application of a geographically matched control population effectively limits the number of candidate disease-causing variants and may provide the means by which variants suitable for functional studies are identified genome wide.

Place, publisher, year, edition, pages
Public Library of Science, 2019
National Category
Medical Genetics
Identifiers
urn:nbn:se:umu:diva-158021 (URN)10.1371/journal.pone.0213350 (DOI)000462465800028 ()30917156 (PubMedID)2-s2.0-85063572524 (Scopus ID)
Funder
Knut and Alice Wallenberg Foundation, 2011.0042
Available from: 2019-04-10 Created: 2019-04-10 Last updated: 2023-03-23Bibliographically approved
Rentoft, M., Lindell, K., Tran, P., Chabes, A. L., Buckland, R., Watt, D. L., . . . Chabes, A. (2016). Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance. Proceedings of the National Academy of Sciences of the United States of America, 113(17), 4723-4728
Open this publication in new window or tab >>Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance
Show others...
2016 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 113, no 17, p. 4723-4728Article in journal (Refereed) Published
Abstract [en]

Even small variations in dNTP concentrations decrease DNA replication fidelity, and this observation prompted us to analyze genomic cancer data for mutations in enzymes involved in dNTP metabolism. We found that sterile alpha motif and histidine-aspartate domain-containing protein 1 (SAMHD1), a deoxyribonucleoside triphosphate triphosphohydrolase that decreases dNTP pools, is frequently mutated in colon cancers, that these mutations negatively affect SAMHD1 activity, and that severalSAMHD1mutations are found in tumors with defective mismatch repair. We show that minor changes in dNTP pools in combination with inactivated mismatch repair dramatically increase mutation rates. Determination of dNTP pools in mouse embryos revealed that inactivation of oneSAMHD1allele is sufficient to elevate dNTP pools. These observations suggest that heterozygous cancer-associatedSAMHD1mutations increase mutation rates in cancer cells.

National Category
Cell and Molecular Biology
Research subject
cell research
Identifiers
urn:nbn:se:umu:diva-119232 (URN)10.1073/pnas.1519128113 (DOI)000374748400052 ()27071091 (PubMedID)2-s2.0-84964773876 (Scopus ID)
Funder
Knut and Alice Wallenberg FoundationSwedish Cancer SocietySwedish Research Council
Available from: 2016-04-14 Created: 2016-04-14 Last updated: 2023-03-24Bibliographically approved
Rentoft, M., Coates, P. J., Loljung, L., Wilms, T., Laurell, G. & Nylander, K. (2014). Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue. Tumor Biology, 35(5), 4191-4198
Open this publication in new window or tab >>Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue
Show others...
2014 (English)In: Tumor Biology, ISSN 1010-4283, E-ISSN 1423-0380, Vol. 35, no 5, p. 4191-4198Article in journal (Refereed) Published
Abstract [en]

Five-year survival for patients with oral cancer has been disappointingly stable during the last decades, creating a demand for new biomarkers and treatment targets. Lately, much focus has been set on immunomodulation as a possible treatment or an adjuvant increasing sensitivity to conventional treatments. The objective of this study was to evaluate the prognostic importance of response to radiotherapy in tongue carcinoma patients as well as the expression of the CXC-chemokines in correlation to radiation response in the same group of tumours. Thirty-eight patients with tongue carcinoma that had received radiotherapy followed by surgery were included. The prognostic impact of pathological response to radiotherapy, N-status, T-stage, age and gender was evaluated using Cox's regression models, Kaplan-Meier survival curves and chi-square test. The expression of 23 CXC-chemokine ligands and their receptors were evaluated in all patients using microarray and qPCR and correlated with response to treatment using logistic regression. Pathological response to radiotherapy was independently associated to overall survival with a 2-year survival probability of 81% for patients showing a complete pathological response, while patients with a non-complete response only had a probability of 42% to survive for 2 years (p = 0.016). The expression of one CXC-chemokine, CXCL10, was significantly associated with response to radiotherapy and the group of patients with the highest CXCL10 expression responded, especially poorly (p = 0.01). CXCL10 is a potential marker for response to radiotherapy and overall survival in patients with squamous cell carcinoma of the tongue.

Keywords
p63, prognosis, tongue carcinoma
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:umu:diva-92407 (URN)10.1007/s13277-013-1549-6 (DOI)000335759800029 ()24395654 (PubMedID)2-s2.0-84902979467 (Scopus ID)
Available from: 2014-08-26 Created: 2014-08-26 Last updated: 2023-03-24Bibliographically approved
Danielsson, K., Boldrup, L., Rentoft, M., Coates, P., Ebrahimi, M., Nylander, E., . . . Nylander, K. (2013). Autoantibodies and decreased expression of the transcription factor ELF-3 together with increased chemokine pathways support an autoimmune phenotype and altered differentiation in lichen planus located in oral mucosa. Journal of the European Academy of Dermatology and Venereology, 27(11), 1410-1416
Open this publication in new window or tab >>Autoantibodies and decreased expression of the transcription factor ELF-3 together with increased chemokine pathways support an autoimmune phenotype and altered differentiation in lichen planus located in oral mucosa
Show others...
2013 (English)In: Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, E-ISSN 1468-3083, Vol. 27, no 11, p. 1410-1416Article in journal (Refereed) Published
Abstract [en]

Background  The pathogenesis of oral lichen planus (OLP), a chronic inflammatory disease, is not fully understood. It is known that OLP has autoimmune features, and it is suggested to be an autoimmune disease. ELF-3 is involved in differentiation of keratinocytes and deregulated in different tumours and inflammatory diseases. CXCR-3 and its ligands CXCL-10 and CXCL-11 are increased in autoimmune diseases and linked to Th-1 immune response. Objectives  To analyse and compare expression of ELF-3, CXCR-3, CXCL-10 and CXCL-11 in OLP lesions and controls in whole and microdissected epithelium. Methods  Tissue biopsies from 20 patients clinically and histologically diagnosed with OLP and 20 healthy controls were studied using whole tissues or microdissected epithelium. By the use of qRT-PCR, mRNA levels of ELF-3, CXCR-3, CXCL-10 and CXCL-11 were studied. Western blot was used for analysis of ELF-3 protein expression. Sera from 19 OLP patients and 20 controls were analysed with ELISA in search for autoantibodies. Results  The upregulation of CXCR-3, CXCL-10 and CXCL-11 found in OLP is similar to previous findings showing an autoimmune phenotype in lichen planus (LP) and lichen sclerosus. Decreased expression of the differentiation-related transcription factor ELF-3 was also seen in OLP lesions, and we further demonstrate presence of circulating autoantibodies against the ELF-3 protein in sera from 3 of 19 (16%) LP patients tested. Conclusions  On the basis of these findings, we confirm that OLP shows features of an autoimmune disease and suggest deregulated differentiation of keratinocytes to be one of the causes of the disease phenotype.

Place, publisher, year, edition, pages
Wiley-Blackwell, 2013
National Category
Basic Medicine Dermatology and Venereal Diseases
Identifiers
urn:nbn:se:umu:diva-55418 (URN)10.1111/jdv.12027 (DOI)000325747200011 ()23134363 (PubMedID)2-s2.0-84885948960 (Scopus ID)
Available from: 2012-05-15 Created: 2012-05-14 Last updated: 2023-03-24Bibliographically approved
Organisations

Search in DiVA

Show all publications